packageMitapivat

mitapivat

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Mitapivat is a hematological drug used to treat hemolytic anemia, a genetic condition. It is authorised in the European Union and is also being investigated for other uses.

Summary written by glm-5.3-flash from Wikidata Q105337735 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:mitapivat
ATC codes:B06AX04
DrugBank:DB16236
PubChem CID:59634741
Wikidata:Q105337735
formula:C24H26N4O3S
molar mass:450.557 g/mol (PubChem CID 59634741)
logP:1.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown